Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

For ovarian cancer, a BRCA1 mutation increases the risk from the 1.3% seen in the general population to 39%, and a BRCA2 mutation raises it to between 11% and 17%.

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Mutations in the BRCA1 gene that are either inherited (germline) or acquired (somatic) might not be key to the initiation of prostate cancer, as previously thought, suggests the first study of its ...

Jen Culton learned she had the BRCA1 gene mutation after her older sister's breast-cancer diagnosis. She decided to have two of her daughters tested; one daughter also has the BRCA1 gene mutation.

The conclusions for BRCA1 mutation carriers were quite different. The authors concluded that BRCA1 carriers who had used oral contraceptives before 1975, before the age of 30 years, ...

Jen Culton learned she had the BRCA1 gene mutation after her older sister's breast-cancer diagnosis. She decided to have two of her daughters tested; one daughter also has the BRCA1 gene mutation.

Although the extent to which different gene mutations increase a woman’s risk of breast cancer isn’t completely understood, it is known that BRCA1 and BRCA2 mutations carry the highest risk.

In their retrospective study, Rebbeck et al [] concluded that in female BRCA1/2 mutation carriers, a BPO may aid in identifying early stage, more treatable ovarian cancer. For those opting for a ...